OTCQX:MRVFF - Post by User
Post by
GRIFF13on Jul 26, 2009 8:31am
453 Views
Post# 16166589
Worth Repeating
Worth RepeatingFrom Stockshaven.com June 16th/09
" In conclusion, Nuvo seems prime to take advantage of their past failures with the FDA and make success of their third opportunity. With two to three hundred million sales from its osteoarthritis treatment, Nuvo, upon approval will quickly become one of the most successful biopharma companies in the industry."
GRIFF